SHILPA MEDICARE Financial Statement Analysis
|
||
The Revenues of SHILPA MEDICARE have increased by 27.12% YoY .
The Earnings Per Share (EPS) of SHILPA MEDICARE has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SHILPA MEDICARE Last 5 Annual Financial Results
[BOM: 530549|NSE : SHILPAMED]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹1,146 Cr | ₹901 Cr | ₹908 Cr | ₹733 Cr | ₹789 Cr |
Expenses | ₹948 Cr | ₹729 Cr | ₹693 Cr | ₹579 Cr | ₹638 Cr |
Operating Profit (Excl OI) | ₹197 Cr | ₹172 Cr | ₹215 Cr | ₹154 Cr | ₹151 Cr |
Other Income | ₹21 Cr | ₹40 Cr | ₹22 Cr | ₹16 Cr | ₹33 Cr |
Interest | ₹41 Cr | ₹22 Cr | ₹4.56 Cr | ₹3.68 Cr | ₹2.66 Cr |
Depreciation | ₹80 Cr | ₹54 Cr | ₹44 Cr | ₹42 Cr | ₹37 Cr |
Profit Before Tax | ₹102 Cr | ₹195 Cr | ₹188 Cr | ₹136 Cr | ₹137 Cr |
Profit After Tax | ₹61 Cr | ₹146 Cr | ₹155 Cr | ₹110 Cr | ₹103 Cr |
Consolidated Net Profit | ₹61 Cr | ₹148 Cr | ₹156 Cr | ₹112 Cr | ₹105 Cr |
Earnings Per Share (Rs) | ₹-3.74 | ₹6.99 | ₹18.13 | ₹19.15 | ₹13.77 |
PAT Margin (%) | -2.94 | 5.29 | 16.22 | 17.02 | 14.93 |
ROE(%) | -1.71 | 3.67 | 10.41 | 12.23 | 9.59 |
ROCE(%) | 0.80 | 5.94 | 10.73 | 12.38 | 10.45 |
Total Debt/Equity(x) | 0.45 | 0.37 | 0.57 | 0.29 | 0.16 |
Key Financials |
||
Market Cap | : | ₹ 5,236.2 Cr |
Revenue (TTM) | : | ₹ 1,123.2 Cr |
Net Profit(TTM) | : | ₹ 5.2 Cr |
EPS (TTM) | : | ₹ 0.5 |
P/E (TTM) | : | 999.3 |
Industry Peers & Returns | 1W | 1M | 1Y |
SHILPA MEDICARE | -1.9% | 8.2% | 115.8% |
SUN PHARMACEUTICAL INDUSTRIES | 0.3% | -7.5% | 53.9% |
CIPLA | 1.1% | -4.8% | 56.4% |
DR REDDYS LABORATORIES | 1.6% | 1.6% | 27.6% |
ZYDUS LIFESCIENCES | 5.2% | -0.2% | 90.1% |
DIVIS LABORATORIES | -1.9% | 10.7% | 21.4% |
MANKIND PHARMA | -2.3% | 0.1% | NA |
TORRENT PHARMACEUTICALS | 1.6% | 2% | 61.8% |
LUPIN | 2.4% | 2% | 132.5% |
SHILPA MEDICARE Revenues
[BOM: 530549|NSE : SHILPAMED]
Y-o-Y | 27.12 % |
5 Yr CAGR | 9.78 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹1,146 Cr | 27.12 | |
Mar2022 | ₹901 Cr | -0.75 | |
Mar2021 | ₹908 Cr | 23.80 | |
Mar2020 | ₹733 Cr | -7.03 | |
Mar2019 | ₹789 Cr | - |
SHILPA MEDICARE Operating Profit
[BOM: 530549|NSE : SHILPAMED]
Y-o-Y | 14.85 % |
5 Yr CAGR | 6.86 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹197 Cr | 14.85 | |
Mar2022 | ₹172 Cr | -19.96 | |
Mar2021 | ₹215 Cr | 39.30 | |
Mar2020 | ₹154 Cr | 1.84 | |
Mar2019 | ₹151 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -9.66 % |
5 Yr CAGR | -2.66 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 17.21% | -9.66 | |
Mar2022 | 19.05% | -19.38 | |
Mar2021 | 23.63% | 12.52 | |
Mar2020 | 21% | 9.55 | |
Mar2019 | 19.17% | - |
SHILPA MEDICARE Profit After Tax
[BOM: 530549|NSE : SHILPAMED]
Y-o-Y | -58.95 % |
5 Yr CAGR | -12.87 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹61 Cr | -58.95 | |
Mar2022 | ₹148 Cr | -5.36 | |
Mar2021 | ₹156 Cr | 39.10 | |
Mar2020 | ₹112 Cr | 6.67 | |
Mar2019 | ₹105 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | -2.94 % | Negative | |
Mar2022 | 5.29 % | -67.39 | |
Mar2021 | 16.22 % | -4.70 | |
Mar2020 | 17.02 % | 14.00 | |
Mar2019 | 14.93 % | - |
SHILPA MEDICARE Earnings Per Share (EPS)
[BOM: 530549|NSE : SHILPAMED]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹-3.74 | Negative | |
Mar2022 | ₹6.99 | -61.45 | |
Mar2021 | ₹18 | -5.33 | |
Mar2020 | ₹19 | 39.07 | |
Mar2019 | ₹14 | - |
SHILPA MEDICARE Return on Capital Employed (ROCE)
[BOM: 530549|NSE : SHILPAMED]
Y-o-Y | -86.53 % |
5 Yr CAGR | -47.40 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 0.8% | -86.53 | |
Mar2022 | 5.94% | -44.64 | |
Mar2021 | 10.73% | -13.33 | |
Mar2020 | 12.38% | 18.47 | |
Mar2019 | 10.45% | - |
SHILPA MEDICARE Share Price vs Sensex
Current Share Price | : | ₹535.4 |
Current MarketCap | : | ₹ 5,236.2 Cr |
Updated EOD on | : | May 03,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHILPA MEDICARE | -1.9% |
8.2% |
115.8% |
SENSEX | -0.6% |
0.3% |
21.8% |
SHILPA MEDICARE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MIDSMALLCAP | 1.4% | 8.6% | 66.5% |
S&P BSE HEALTHCARE | 0.8% | 1.5% | 55.8% |
S&P BSE ALLCAP | 0.4% | 3.7% | 40% |
S&P BSE SMALL CAP | 0.2% | 9.3% | 64.7% |
You may also like the below Video Courses
FAQ about SHILPA MEDICARE Financials
How the annual revenues of SHILPA MEDICARE have changed ?
The Revenues of SHILPA MEDICARE have increased by 27.12% YoY .
How the Earnings per Share (EPS) of SHILPA MEDICARE have changed?
The Earnings Per Share (EPS) of SHILPA MEDICARE has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs